New eye drops show promise for aging eyes in Long-Term safety trial
NCT ID NCT05753189
First seen May 15, 2026 · Last updated May 23, 2026 · Updated 1 time
Summary
This study tested the long-term safety of LNZ101 eye drops for presbyopia, a common age-related condition that makes it hard to see things up close. A total of 362 adults aged 45 to 75 took part. The main goal was to check for side effects related to the treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EYE DISEASES are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Site #301
Overland Park, Kansas, 66210, United States
-
Site #302
Chandler, Arizona, 85224, United States
-
Site #303
Garden Grove, California, 92843, United States
-
Site #304
Santa Barbara, California, 93105, United States
-
Site #306
Petaluma, California, 94954, United States
-
Site #307
Pittsburg, Kansas, 66762, United States
-
Site #308
Littleton, Colorado, 80120, United States
-
Site #309
Mt. Dora, Florida, 32757, United States
-
Site #310
Fargo, North Dakota, 58103, United States
-
Site #311
Smyrna, Tennessee, 37167, United States
-
Site #312
Cranberry Township, Pennsylvania, 16066, United States
-
Site #313
Glendale, California, 91204, United States
-
Site #314
El Paso, Texas, 79902, United States
-
Site #315
Memphis, Tennessee, 38104, United States
-
Site #316
Danbury, Connecticut, 06810, United States
-
Site #317
Rock Island, Illinois, 61201, United States
-
Site #318
San Antonio, Texas, 78229, United States
-
Site #319
Crystal River, Florida, 34429, United States
-
Site #320
Mesa, Arizona, 85202, United States
-
Site #321
Phoenix, Arizona, 85032, United States
-
Site #322
Newport Beach, California, 92663, United States
-
Site #323
Powell, Ohio, 43065, United States
-
Site #324
Louisville, Kentucky, 40206, United States
-
Site #325
St Louis, Missouri, 63128, United States
-
Site #326
Dothan, Alabama, 36301, United States
-
Site #327
San Antonio, Texas, 78229, United States
-
Site #328
Phoenix, Arizona, 85053, United States
-
Site #329
Cincinnati, Ohio, 45242, United States
-
Site #330
Kansas City, Missouri, 64154, United States
-
Site #331
Sun City, Arizona, 85351, United States
-
Site #332
West Fargo, North Dakota, 58078, United States
-
Site #333
Eugene, Oregon, 97401, United States
-
Site #334
La Jolla, California, 92037, United States
-
Site #335
Bozeman, Montana, 59718, United States
-
Site #336
Alexandria, Minnesota, 56308, United States
-
Site #337
Rancho Cordova, California, 95670, United States
-
Site #338
Scottsdale, Arizona, 85260, United States
-
Site #339
Morrow, Georgia, 30260, United States
-
Site #340
Northbrook, Illinois, 60062, United States
-
Site #341
Dover, New Jersey, 07801, United States
Conditions
Explore the condition pages connected to this study.